Hodgkin's research is being conducted to better understand and treat Hodgkin's disease. Research trials now under way are studying the effectiveness of using new chemotherapy drugs, stem cell transplants, and biological therapy to treat Hodgkin's disease. Patients who volunteer to participate in Hodgkin's research help doctors learn more about the disease. They may also benefit from being among the first to receive treatments that have shown promise in earlier research.
Doctors and scientists all over the country are conducting Hodgkin's disease research. Hodgkin's research studies are designed to answer important questions and to determine whether new approaches are safe and effective. While Hodgkin's research already has led to many advances, researchers continue to search for more effective methods of dealing with the disease.
Hodgkin's Research: Treatment Trials
Many people with Hodgkin's disease take part in Hodgkin's research trials. Doctors conduct research trials to learn about the effectiveness and possible side effects of new treatments.
Current Hodgkin's research trials are exploring:
- New ways of administering radiation therapy and chemotherapy
- New drugs and new drug combinations
- Biological therapies.
High-dose chemotherapy with bone marrow or peripheral blood stem cell transplantation is also being evaluated.
In some Hodgkin's research trials, all patients receive the new treatment. In others, doctors compare different therapies by giving the new treatment to one group of patients and the standard treatment to another group, or they may compare one standard Hodgkin's disease treatment with another.